Patent Abstract:
An implantable esophageal sphincter apparatus with an adjustable band to be placed at the lower part of the esophagus. The inflation of the band, or sphincter body, can be increased or decreased to adjust the tightness of the device. The inflatable sphincter body may be wrapped around the esophagus and may be connected to an inflation device with a fluid reservoir. The inflation device may have a pump mechanism that will respond to external control to increase or decrease the inflation of the sphincter body. The sphincter apparatus will be held in place at the area of implantation by sutures and by fenestration mechanisms, which will allow ingrowths of tissue or fibrous elements of the body around the sphincter apparatus or into porous materials on the sphincter apparatus. The apparatus may also include a circumferential shield on a distal side of the sphincter apparatus. The shield is adapted to fit against the distal or lower side of the patient&#39;s diaphragm and inhibits the development of a hiatus hernia, that is, a protrusion of the stomach past the diaphragm through the passage for the esophagus.

Full Description:
FIELD OF THE INVENTION 
     The present invention relates to an implantable apparatus for use treating gastroesophageal acid reflux and particularly to an artificial sphincter for the lower esophageal sphincter. 
     BACKGROUND OF THE INVENTION 
     Gastroesophageal reflux disease (GERD) is one of the most common medical illnesses in today&#39;s western society. Gastroesophageal reflux occurs when the contents of the stomach, including acids and digestive fluids, leak back past the lower esophageal sphincter into the esophagus. This produces the sensation commonly referred to as “heartburn”. Over prolonged periods, this condition can seriously compromise a person&#39;s health. Studies indicate that the incidence of gastroesophageal reflux is on the rise. For example, health care providers use Common Procedural Terminology (“CPT”) codes to report treatment of certain conditions. In 1999, the CPT code for GERD was the most commonly used code from gastroenterologists&#39; offices in the United States, indicating the prevalence of the condition. Incidence of this disease is similarly common in all parts of Europe and probably in any affluent society. 
     Currently, there are four options available for treatment of gastroesophageal reflux disease. These options are life-style modification, medication, surgery, and endoscopic fundoplication. Life-style modification comprises dietary changes and positioning of body so that, with the help of gravity, upward reflux of food and acid from the stomach is prevented. This treatment is seldom effective alone. 
     Medication is the most common treatment. Depending upon the degree of severity, a physician may prescribe medications ranging from less potent acid-blockers like Ranitidine (the so-called “Histamine 2 receptor blocker”) to strong acid-production blockers like Prilosec (the Proton pump inhibitors—PPI). The results from treatment by medication are quite satisfactory in the majority of the cases. The problems are the need to take medication for the remainder of the patient&#39;s life with its enormous cost, the inconvenience of constantly keeping medicine with the patient, and the long-term concern about strong acid inhibition as a side effect of the medication. There is some data suggesting that atrophic gastritis may develop in some patients as a result of longterm therapy by medication. There is also a phenomenon called acid-rebound after discontinuation of medication. Finally, although medical therapy is effective against acid reflux conditions, it is not effective in controlling so-called “alkaline” or “bile” reflux. 
     Surgical therapy is currently recommended for the patients whose symptoms are not controlled by medication or for the patients who do not want to take long-term medication. Both traditional surgical procedures and laparoscopic approaches have been tried. Recent literature suggests that there may be significant long-term concerns with regard to the laparoscopic approach. Of course, the patient has to be physically fit to undergo such a procedure. In spite of cost, the difficulty of patient selection and the invasiveness involved, approximately 80,000 of these procedures were performed in the United States in 1999. 
     Endoscopic fundoplication is a very recent procedure done by the gastroenterologists. It consists of securing a suture in a purse-string-like configuration to the part lower part of the esophagus or upper part of the stomach, which basically creates an additional mechanical barrier to the contents of reflux from the stomach to esophagus. The data is very preliminary on this procedure and very few gastroenterologists are trained to perform it. Even in the best case, there are significant limitations to the procedure and some patients with large hiatus hernia will not qualify for this. 
     SUMMARY OF THE INVENTION 
     Despite multiple treatment options, treatment of GERD still needs improvement in long-term, low-cost treatment. Therefore, there is room for improvement in this area. I plan to accomplish this by an implantable esophageal sphincter apparatus, described below. 
     The apparatus comprises an adjustable band or sphincter body to be placed at the lower part of esophagus, most of the time over or around the Lower Esophageal Sphincter (LES) or around the very first part of stomach adjoining the esophagus. The internal inflation of the band can be increased or decreased to some extent, which in turn will adjust the tightness of the device. This will meet the need for some patients who might find it easier to swallow with a loose band and subsequently make it tighter to prevent reflux. The device will be of human-grade implantable material. The device will enhance the normal tone or pressure of the LES that naturally exists in the competent LES. In many cases, this natural tone is lost or these patients have more frequent LES relaxation than normal. This leads to chronic GERD. Placement of the esophageal band will prevent these phenomena from occurring and thereby prevent GERD. In short, this will mimic the normal human physiology by a mechanical means. This will promote the natural pressure barrier between the esophagus and stomach that naturally exists in normal physiologic state. The end result will be prevention of reflux and thereby GERD. 
     The apparatus will be implanted in a single surgical procedure. Most of the time, it could be placed by laparoscopic methods, which will minimize the invasiveness of the surgery and will lessen the duration of hospitalization. In some situations, a traditional open surgical method may be required. After gaining access in the abdominal or thoracic cavity either by laparoscopic or open surgical technique, the surgeon will isolate the area of the lower esophageal sphincter and the esophago-gastric junction (EGJ). During this procedure, an endoscope or a bougie of a satisfactory diameter placed per orally will give both guidance to the degree of tightness and protection to the esophagus. An inflatable sphincter body may be wrapped around the esophagus and may be connected to an inflation device with a fluid reservoir. The inflation device and reservoir may be implanted underneath the skin of the anterior chest wall or of the abdominal wall during the same surgical procedure with the sphincter body. The inflation device may have a pump mechanism that will respond to external control to increase or decrease the inflation of the sphincter body that, in turn, will either increase or decrease the tightness of the area upon which the sphincter body is placed (usually at the lower esophageal sphincter). The sphincter body may be held in place at the area of implantation by sutures and by fenestration mechanisms, which will allow ingrowths of tissue or fibrous elements of the body around the sphincter body or into porous materials on the sphincter body. After placement of the full device, the physician or surgeon will activate the pump mechanism and test the response of the mechanism before final closure. 
     The apparatus may also include a circumferential shield on a distal side of the sphincter body. The shield is adapted to fit against the distal or lower side of the patient&#39;s diaphragm and inhibits the development or re-occurrence of a hiatus hernia, that is, a protrusion of the stomach past the diaphragm through the passage for the esophagus. The apparatus, therefore, also provides a treatment for hiatus hernias. 
     A patient would undergo normal pre-surgical evaluation to determine suitability as a surgical candidate. Both gastroenterologists and surgeons with appropriate interests and competency in reflux treatment procedures should usually be consulted. Tests may include upper gastrointestinal endoscopy, and 24-hour pH and motility testing. These tests would provide objective evidence of GERD in the patient involved, including evidence of severity of damage, anatomic integrity of the organs involved, associated co-existing diseases that can effect patient&#39;s outcome and the extent and severity of reflux itself. In addition, certain radiological testing to image the upper gastrointestinal organs may also be an integral part of this evaluation. 
     After implantation of the apparatus, a physical examination of the patient may be conducted to reevaluate signs and symptoms as they pertain to the patient&#39;s pre-surgical and post-surgical outcome. If appropriate, endoscopy, 24-hour pH and motility studies may also be included in the post-surgical testing. Certain radiological testing, such as a CT scan, or upper gastrointestinal radiology, may be included. 
     It is an object of my invention, therefore, to provide an apparatus for the treatment of gastroesophageal reflux disease. Another object of my invention is to provide an apparatus having a prosthetic sphincter body for placement at or near the lower esophageal sphincter. 
     Yet another object of my invention is to provide a sphincter body that is inflatable to predetermined size. 
     Another object of my invention is to provide an artificial sphincter body that cannot be closed beyond a predetermined minimum orifice size. A further object of my invention is to provide control mechanisms for controlling the size of the sphincter body. 
     Another object of my invention is to provide an artificial sphincter body for the esophagus with a gap or opening to allow the sphincter body to be placed around the esophagus. 
     It is also an object of my invention to provide an implantable prosthetic sphincter having a shield to prevent development or re-occurrence of hiatus hernias of the stomach through the diaphragm. 
     These and other features and advantages of the present invention will be apparent to one skilled in the art from the following detailed description, connection with the accompanying drawings. 
    
    
     BRIEF DESCRIPTION OF THE DRAWINGS 
     FIG. 1 is a representation of a patient with a prosthetic sphincter apparatus according to my invention implanted near the lower esophageal sphincter of the patient. 
     FIG. 2 is a perspective view of an implantable prosthetic sphincter apparatus according to the present invention. 
     FIG. 3 is a top plan view of the prosthetic sphincter apparatus of FIG.  2 . 
     FIG. 4 is a block diagram of a control mechanism for use with the apparatus of the present invention. 
     FIG. 5 is a perspective view of a manual pump for use with the present invention. 
     FIG. 6 is a through section view of the manual pump of FIG.  5 . 
     FIG. 7 is a perspective view of an implantable esophageal sphincter body with diaphragm shield. 
    
    
     DETAILED DESCRIPTION 
     I will now describe my invention with reference to the accompanying drawings, wherein like numerals are used to describe like parts in the various views. FIG. 1 illustrates an implantable esophageal sphincter apparatus  10  in a patient  12 . The apparatus  10  comprises a toroidal sphincter body  14  that is placed around the esophagus  16  of the patient  12  adjacent the lower esophageal sphincter  18 . The sphincter body  14  would usually be implanted above the patient&#39;s stomach  20  and preferably immediately above the diaphragm  22 . The diaphragm is a domed, muscular layer of tissue separating the abdomen and the thorax. A tube  24  connects the sphincter body  14  to a control apparatus  26  that regulates the size of the sphincter body  14 , as explained hereafter. 
     The sphincter body  14  comprises a generally toroidal inflatable bladder  28  having an inner wall  30  and an outer wall  32 . Preferably, the bladder  28  also has a first end  34  and a second end  36  forming a gap  38 . Viewed from above, as in FIG. 3, the sphincter body forms a “C”, a structure that allows the sphincter body  14  to be placed around the esophagus  16  by passing the esophagus through the gap  38 . A clasp  40  on the outer wall  32  near the first end  34  connects to an anchor  42  on the outer wall  32  near the second end  36 , allowing the two ends to be tied together after the sphincter body  14  has been placed around the patient&#39;s esophagus. The clasp and anchor may take any suitable form. For example, the clasp  40  may be a pre-threaded suture  44  with attached needle  46  having a distal end permanently attached to the sphincter body, as illustrated in FIG. 2, and the anchor  42  may be a sewing tab  48 . Alternatively, sewing tabs could be provided on both the first and second ends and an ordinary prethreaded suture could be threaded through both tabs to hold the ends together. Another type of clasp  40  is shown in FIG.  3 . The clasp  40  may comprise a strip  50  of hook-and-eye fastener, and the anchor  42  may be a mating piece  52  of hook-and-eye material. A third embodiment of a clasp  40 , as shown in FIG. 7, may comprise an elastomeric filament  54  having teeth along one side. The filament  54  engages a receptacle  56  having an opening  58  with a spring latch for connecting with the teeth, in the manner of a cable tie. After the gap is closed, excess length of the male filament could be trimmed away. Other specific forms for the clasp and anchor will suggest themselves to one of skill in the art. 
     When the sphincter body  14  has been placed around the esophagus, it is desirable to control the size of a central opening  60  through the sphincter body  14 . The inflatable bladder tends to expand radially when filled with fluid. An inextensible outer surface  62  adjacent the outer wall  32  of the bladder  28  constrains the bladder so that the central opening  60  becomes smaller rather than larger as the bladder is filled. The surface  62  may be an inextensible polymeric substance such as polyamide. It may also be a rigid structure of, for example, titanium, Elgiloy (trademark) steel, or other implantable material. 
     The lower esophageal sphincter allows food to pass from the esophagus into the stomach, but prevents acidic stomach contents from entering and damaging the esophagus. This can be accomplished without completely closing the sphincter. Thus, if the sphincter body  14  can restore some of the effectiveness of the sphincter by partially closing the sphincter. Food can still pass into the stomach, but either acid or bilious reflux is minimized or eliminated, without continually adjusting the sphincter body. It is important, therefore, that the sphincter body close only to a predetermined minimum diameter. A relatively inextensible, flexible skin  64  adjacent the inner wall of the bladder  28  and connected to the inextensible outer surface, prevents the sphincter body from closing completely, and preferably from completely closing the lower esophageal sphincter within the sphincter body  28 . Preferably, the minimum inside diameter of the esophagus should be not less than about 45 French (15 mm), and more preferably not less than about 54 French (18 mm). Such an opening will allow food to be swallowed, yet inhibit either acid or bilious reflux. The wall of the esophagus is usually between 2 mm or 3 mm thick. The central opening  60  of the sphincter body should be not less than about 57 French (19 mm), or more preferably not less than about 66 French (22 mm). In some patients, the benefits may be obtained with a larger central opening, allowing larger portions of food to be swallowed comfortably. Less inflation of the bladder produces a larger central opening. 
     The control apparatus  26  regulates the amount of a fluid, such as normal saline solution, that fills the sphincter body  14 . Although the control apparatus  26  may adjoin the sphincter body  14 , it is preferable that the control apparatus be spaced away from the sphincter body in a more accessible area of the body. A tube  24  with at least one lumen for carrying fluid to and from the sphincter body  14  connects the sphincter body and the control apparatus. A control apparatus illustrated in FIG. 2 comprises an implantable chamber  66  having a fluid container  68  with a pierceable septum  70 . The tube  24  communicates with the fluid container  68  through a nipple  72 . The chamber  66  is implanted beneath the patient&#39;s skin and is accessible by a needle inserted through the skin and septum  70 . Fluid can be inserted into or withdrawn from the chamber  66  with a syringe. The fluid will, in turn, inflate or deflate the bladder in the sphincter body, thereby enlarging or decreasing the size of the central opening  60 . 
     The control apparatus  26  may also be an implantable electrically controlled pump  74 , illustrated in block diagram in FIG.  4 . The electrically controlled pump  74  comprises a bi-directional fluid pump  76  connected to a battery power supply  78 , a fluid reservoir  80 , and the tube  24  leading to the sphincter body. A receiver-controller  82  receives instructions transmitted from an external control device  84  and causes the pump  76  to move fluid into or out of the sphincter body. An electrical conductor  86  connects the controller  82  to a sensor  88 , such as a strain gauge or a pressure sensor, mounted on the sphincter body  14  (FIG.  3 ). In response to detected changes, the electrically controlled pump  74  may decrease or increase the central opening  60 . The sensors  88  could also detect whether the increased pressure is on the upper (or esophageal) side of the sphincter body or on the lower (or stomach) side, and respond accordingly. For example, increased pressure on the upper side may indicate that the patient is attempting to swallow, and the central opening may need to be enlarged. Increased pressure on the lower side may indicate an increased chance for either acid or bilious reflux, and the central opening may need to be reduced. The receiver  82 , fluid reservoir  80 , pump  76  and battery  78  should all be enclosed in a case  90  which is impervious to body fluids. Suitable titanium cases are well known from other types of implantable medical devices, for example, implantable pacemakers. 
     A third example of a control apparatus  26  is shown in FIGS. 5 and 6. The apparatus is a manually controlled pump  92 . The manually controlled pump  92  has a case  94  with a deflectable diaphragm  96  and a reversible valve  98 . The reversible valve  98  communicates with the tube  24 . As seen best in FIG. 6, the manually controlled pump  92  has a chamber  100  inside the case  94 . A collapsible bag  102  in the chamber contains a supply of fluid. The bag communicates with a pumping chamber  104  under the deflectable diaphragm  96  through a one-way valve  106  in a partition  108 . The partition  108  separates the chamber  100  and collapsible bag  102  from the pumping chamber  104 . The manually controlled pump  92  is implanted beneath the skin of the patient so that the patient can press on the diaphragm  96  and force fluid through a second one-way valve  110  into the tube connected to the sphincter body. This action will fill and expand the sphincter body, decreasing the size of the central opening, and closing the esophagus. To reverse the flow and open the sphincter body, the patient would place a magnet over the manually controlled pump  92 . The magnet displaces a metallic dam  112  from a normal position covering a third one-way valve  114  to a temporary position blocking the second one-way valve  110 . A small leaf spring  116  holds the metallic dam  112  in its normal position, but it is not strong enough to resist the magnetic attraction applied to the metallic dam  112 . With the third valve  114  exposed, fluid flows back into the bag  102 , driven by the elastic bladder in the sphincter body. The patient is thereby able to adjust the opening in the sphincter body within the limits imposed by the inextensible outer surface  62  and the inextensible, flexible skin  64 . 
     The esophagus passes through a “hiatus”, or opening, in the diaphragm before reaching the stomach. As a consequence either of the physical debilities attending acid reflux disease or of the surgery recommended to treat the disease, the esophageal hiatus may become enlarged and a hiatus hernia may develop. A hiatus hernia is a protrusion of the stomach upward into the mediastinal cavity through the esophageal hiatus of the diaphragm. To correct or to avoid the development of this condition, a shield  118  may be provided on the sphincter body  14 . The shield  118  comprises a generally circular sheet  120  of biologically compatible material attached to a distal side  122  of the sphincter body  14 . Suitable materials may be knitted or woven Dacron (trademark) cloth or Gore-Tex (trademark) material. The sheet  120  has an opening  124  corresponding to the central opening  60  of the sphincter body  14 . A slot  126  extends through the sheet  120  from the gap  38  in the sphincter body  14  to an outer edge  128  of the sheet  120 . Additional slots may be provided to allow the sheet to conform to the concave underside of the diaphragm, or the sheet may be shaped to approximate the expected shape of the diaphragm. 
     An interior region  130  of the sheet adjacent the sphincter body  14  and extending a selected distance radially outward from the sphincter body  14  is relatively stiff and provides a barrier at the esophageal hiatus. An outer region  132  between the inner region  130  and the outer edge  128  is more flexible and may be adapted to encourage tissue growth into the material of the outer region. This would tend to anchor the shield  118  to the diaphragm. The shield may also the sutured to the diaphragm, particularly posteriorly near the crura of the diaphragm, that is, to the tissues connecting the diaphragm to the back. A notch  134  may be provided in the right anterior part of the outer region  130  so that the shield would not be in contact with the lower vena cava. Similarly a second notch  136  at the anterior side of the shield so that the shield would not be in contact with the descending aorta. The tube  24  should be connected to the distal side  122  of the sphincter body  14  and extend through the shield  118 . To implant the apparatus, the sphincter body  14  would preferably be pushed through the diaphragm like a plug, thereby bringing the shield  118  to rest adjacent the distal, or bottom, side of the diaphragm. The tube  14  and control apparatus  26  would be implanted in the abdominal cavity. 
     Although I have now described my invention in connection with my preferred embodiment, those skilled in the art will recognize that my invention may take other forms without departing from the spirit or teachings thereof. The foregoing description is intended, therefore, to be illustrative and not restrictive, and the scope of my invention is to be defined by the following claims .

Technology Classification (CPC): 0